Clinical Trial Update: Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate [NA]

View source ↗

Summary

A completed clinical trial assessing changes in inflammatory cytokines in tears of patients with moderate to severe Meibomian Gland Dysfunction treated with top…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meibomian Gland Dysfunction

Drugs mentioned

• Lotemax (Loteprednol etabonate)

Snippet

Sponsor: Yonsei University | Conditions: Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction) | NA | Status: COMPLETED